(Reuters) - He said the company has not quite decided on the financing mix.
On March 12, Schering-Plough agreed to buy Dutch chemical group Akzo Nobel NV's drugs unit Organon for 11 billion euros in a bid to gain scale and diversify away from cholesterol medicine.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment